1h Free Analyst Time
The vascular embolization devices market is forecasted to grow by USD 735.35 mn during 2023-2028, accelerating at a CAGR of 6.69% during the forecast period. The report on the vascular embolization devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of vascular diseases, a rising number of new product launches related to vascular embolization devices, and a growing number of m and activities in related vascular disease products.
The vascular embolization devices market is segmented as below:
By End-user
- Hospitals
- Speciality clinics
- ASCs
By Product
- Coiling devices
- Non-coiling devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the vascular embolization devices market covers the following areas:
- Vascular embolization devices market sizing
- Vascular embolization devices market forecast
- Vascular embolization devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global vascular embolization devices market: Acandis GmbH, B.Braun SE, BALT Group, Boston Scientific Corp., Braile Biomedica, Eisai Co. Ltd., Embolx Inc., Guerbet, Johnson and Johnson Services Inc., Kaneka Corp., Medtronic, Merit Medical Systems Inc., Penumbra Inc., Shape Memory Medical Inc., Spartan Micro Inc., Stryker Corp., Wallby Medical LLC, Terumo Corp., Cook Group Inc., and Abbott Laboratories.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the rise in cases of automobile accidents."
According to the report, one of the major drivers for this market is the increasing prevalence of vascular diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acandis GmbH
- B.Braun SE
- BALT Group
- Boston Scientific Corp.
- Braile Biomedica
- Eisai Co. Ltd.
- Embolx Inc.
- Guerbet
- Johnson and Johnson Services Inc.
- Kaneka Corp.
- Medtronic
- Merit Medical Systems Inc.
- Penumbra Inc.
- Shape Memory Medical Inc.
- Spartan Micro Inc.
- Stryker Corp.
- Wallby Medical LLC
- Terumo Corp.
- Cook Group Inc.
- Abbott Laboratories
